| 标题 |
Cost-effectiveness analysis of tislelizumab plus chemotherapy as first-line treatment for HER2-negative advanced gastric or gastro-oesophageal junction adenocarcinoma |
| 网址 | |
| DOI | |
| 其它 |
期刊:Frontiers in Pharmacology 作者:Liangliang Zou; Guilan Guo; Yufan Huang; Cuihua Yuan 出版日期:2025-05-22 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)